NCT05186038View on ClinicalTrials.gov

Mass Screening for the Early Detection of Patients With Celiac Disease.

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 18, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

December 31, 2022

Conditions
Celiac Disease
Interventions
DIAGNOSTIC_TEST

iVYCHECK GIP Urine

To determine the presence of Gluten Immunogenic Peptides (GIP) in urine samples using the immunochromatographic test iVYCHECK GIP Urine (Biomedal S.L).

DIAGNOSTIC_TEST

CeliacDetect

To determine the presence of IgA anti-tTG antibodies in blood samples using the immunochromatographic test CeliacDetect (Biomedal S.L).

Trial Locations (2)

28011

37th Celiac Festival, Madrid

41014

Grupo IHP, Seville

Sponsors

Lead Sponsor

Biomedal S.L.
All Listed Sponsors
collaborator

University of Seville

OTHER

collaborator

FUNDACION IHP

UNKNOWN

lead

Biomedal S.L.

OTHER